Elkfork Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$8.33M Buy
113,356
+43,656
+63% +$3.17M 0.2% 98
2019
Q2
$5M Buy
69,700
+33,592
+93% +$2.38M 0.12% 158
2019
Q1
$2.48M Sell
36,108
-8,602
-19% -$556K 0.06% 237
2018
Q4
$2.66M Buy
44,710
+3,060
+7% +$191K 0.08% 226
2018
Q3
$2.79M Sell
41,650
-135,048
-76% -$9M 0.07% 238
2018
Q2
$11.5M Buy
176,698
+7,888
+5% +$516K 0.29% 78
2018
Q1
$12.1M Sell
168,810
-8,398
-5% -$604K 0.33% 69
2017
Q4
$13.4M Sell
177,208
-7,820
-4% -$571K 0.36% 64
2017
Q3
$13.5M Sell
185,028
-17,068
-8% -$1.23M 0.39% 55
2017
Q2
$15M Sell
202,096
-55,658
-22% -$4.13M 0.45% 50
2017
Q1
$18.9M Buy
257,754
+8,840
+4% +$619K 0.58% 42
2016
Q4
$16.3M Buy
+248,914
New +$17.1M 0.54% 46

Other funds holding CL

Elkfork Partners's CL Position: Q3 2019 in Review

Elkfork Partners increased its Colgate-Palmolive (CL) stake by 63% in Q3 2019, buying an estimated $3.17M and bringing the position to 113,356 shares worth $8.33M. The position accounts for 0.2% of the portfolio, ranked #98.

Elkfork Partners first reported a position in CL in Q4 2016 and has held it in 12 quarters since. The position peaked at $18.9M in Q1 2017. 1,447 funds tracked by Wall St. Rank hold CL as of Q3 2019.

  • Elkfork Partners held 113,356 shares of Colgate-Palmolive worth $8.33M as of Q3 2019.
  • Elkfork Partners bought 43,656 Colgate-Palmolive shares in Q3 2019, an estimated $3.17M.
  • Colgate-Palmolive made up 0.2% of Elkfork Partners's portfolio in Q3 2019, its #98 holding.
  • Elkfork Partners first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Colgate-Palmolive position peaked at $18.9M in Q1 2017.
  • 1,447 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.